Cover Image

Combined estimation of Procalcitonin (PCT) and Lactate in sepsis patients under intensive care in a tertiary care hospital

INDHU K KADHIRSELVAN

Abstract


Sepsis occurs in approximately 2 percent of all  hospitalizations in developed countries and between 6-30 percent of all intensive care unit (ICU) patients. Biomarkers can help in early diagnosis, evaluation of severity, prognosis,             predicting the complications of sepsis and development of organ dysfunction. Procalcitonin (PCT), a precursor of the hormone calcitonin has been proposed as a more specific and better prognostic marker. Serum PCT levels have also been noted to increase with increasing severity of sepsis and organ                   dysfunction. Sepsis is also understood to be a state of anaerobic metabolism and delivers the products of the same to tissues especially the organs with a high metabolic rate. Lactate is a by-product of anaerobic metabolism and hence considered as a marker for tissue hypoperfusion. Surviving sepsis campaign recommends lactate level estimation at admission in deciding the management of sepsis patients. PCT was the best independent variable to identify sepsis and lactate was the best to diagnose severe sepsis. So combined testing for PCT and lactate might offer more insight into the prognosis and                management of sepsis patients.

 


Full Text:

PDF

References


Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit. Care Med. 2006; 34(2): 344–353

Parrillo JE, Parker MM, Natanson C, et al. Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann. Intern. Med. 1990; 113(3): 227–242.

Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 2003; 348(16): 1546–1554.

Biomarkers Definitions Working Group: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95.

Gendrel D, Bohuon C. Procalcitonin as a marker of bacterial infection. Pediatr Infect Dis J 2000; 19: 679-688.

Becker KL et al. Procalcitonin and the Calcitonin Gene family of Peptides in Inflammation, Infection and Sepsis: A journey from Calcitonin back to precursors. J Clin Endocrinol Metab 2004; 89(4): 1512- 1525

Clec’h C, et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit Care Med 2004; 32(5): 1166-1169

Rey C, Los Arcos M,et al. Procalcitonin and C-reactive protein as marker of systemic inflammatory response syndrome in critically ill children. Intensive Care Med 2007; 33: 477-484

Meisner M, Tschaikowsky K, Palmaers T, Schmidt J: Comparison of procalcitonin (PCT) and Creactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999; 3: 45-55.

David B. Sacks. Carbohydrates In: Burtis CA, Ashwood ER, editors. Tietz textbook of Clinical Chemistry. 3rd ed. Philadelphia: W.B Saunders Company; 1999; 787-790

Koliski A, Cat I, Giraldi DJ, Cat ML: Blood lactate concentration as prognostic marker in critically ill children. J Pediatr (Rio J) 2005; 81(4): 287–292.

Bakker J, Gris P, Coffernils M, Kahn RJ, Vincent JL. Serial blood lactate levels can predict the development of multiple organ failure following septic shock. Am J Surg. 1996; 171(2): 221-226.

Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41: 580-637.

Robert S. Munford. Severe Sepsis and Septic Shock. Harrison’s principles of internal medicine.18th ed: The McGraw-Hill companies, 2012; p 2223.

R C Bone et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-1655

Castelli G, Pognani C, Cita M, Paladini R. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med; 2009 Jun; 37(6): 1845-9.

Uzzan B, Cohen R, Nicholas P, et al. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006; 34: 1996-2003.

Giamarellos-Bourboulis EJ, Mega A, Grecka P, et al. Procalcitonin: a marker to clearly differentiate systemic inflammatory response syndrome and sepsis in the critically ill patient? Intensive Care Med 2002;28:1351-6.

Philippe Marty et al. Lactate clearance for death prediction in severe sepsis or septic shock patients during the first 24 hours in Intensive Care Unit: an observational study. Annals of Intensive Care 2013; 3:3

Simos AW, Gibbs MA, Marx JA, et al. Value of point-of-care blood testing in emergent trauma management. J Trauma. 2000; 48(6): 1101-1108.

Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med. 2004; 32(8): 1637-1642.

Phua J, Koay ES, Lee KH.Lactate. Procalcitonin and amino-terminal pro-B-type natriuretic peptide versus cytokine measurements and clinical severity scores for prognostication in septic shock. Shock 2008; 29: 328-33.

Chan Y-L,Tseng C-P,Tsay P-K, et al. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care Med. 2004; 8: 12-20


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University